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ABSTRACT. Down syndrome (DS) is the most frequent chromosome 
abnormality among live births. Its prevalence increases with maternal 
age, and can be diagnosed by antenatal screening. We examined preva-
lence variations of DS in Denizli, Turkey, through a retrospective study. 
Sixteen years of survey data were retrieved from the two main state hos-
pital registries from records between 1994 and 2010. We identified 113 
DS live births in Denizli for 16 years. The prevalence of DS was 9.07 
per 10,000 live births before the year 2000 and 9.90 after 2000. The 
prevalence did not change significantly. The population in Turkey is still 
young; the fertility rate is high in women under 35 years old and prenatal 
screening programs are extensively applied; for these reasons, the preva-
lence of DS has remained stable during these 16 years.
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INTRODUCTION
Down syndrome (DS) (OMIM, 2011), trisomy 21, is the most frequent chromosome 
abnormality among live births. The additional chromosome 21 arises most commonly as a re-
sult of non-disjunction in maternal meiosis or chromosomal translocations. DS mainly causes 
mental retardation associated with a number of medical problems that may lower life quality 
and shorten life expectancy. Congenital heart disease is the most frequent systemic malforma-
tion; it is present in 16-62% of cases (Mihci et al., 2010). Subjects with DS have increased sus-
ceptibility to bacterial and viral infections, malignancies, and autoimmune disorders, which 
increase mortality and morbidity (Cetiner et al., 2010).
The prevalence of DS has been related to maternal age; the risk of having a child 
with DS is increased by age, from 1/1300 to 1/30, in mothers from 25 to 45 years old (Kuller 
and Laifer, 1995). WHO reported that the estimated incidence of DS is from 1 in 1000 to 1 
in 1100 live births worldwide. Each year approximately 3000 to 5000 children are born with 
this chromosome disorder, and it is believed that there are about 250,000 families in the USA 
who are affected by DS (WHO - Genomic Resources Center - Genes and Human Disease 
- Chromosomal Diseases - Down Syndrome, 2011). The average incidence in the USA is 
1/700-800 live births. In addition, prevalence has been associated with ethnicity (Tran et al., 
2005). Since younger women have a higher birth rate, 75% of affected children are born to 
women under 30 years old (Boduroglu et al., 2004). The live birth prevalence of DS can be 
decreased by antenatal screening and amniocentesis, followed by elective abortion. However, 
amniocentesis is an invasive procedure, with a slight abortion risk, and incurs substantial 
expenses; thus, it is not commonly offered to pregnant women under 35 years old. Neverthe-
less, more than 80% of DS are born to mothers under 35 years old. In developed countries, 
due to enhancing qualified health welfare and a high proportion of the elderly population who 
have a high fertility rate, the prevalence increases in women over 35 years old (Adams et al., 
1981; Jou et al., 2005).
Sociocultural-economical and demographical characteristics vary in the various re-
gions of Turkey. Denizli is one of the most important industrial and agricultural major cities 
in the west; it has mixed socio-economic characteristics due to migration into the city. We 
examined the prevalence variations of DS during a 16-year period in Denizli.
MATERIAL AND METHODS
We included survey data retrieved between January 1994 and September 2010. Cases were 
from two state hospital registries and logs and we included cases that had a DS diagnosis indicated 
by ICD-90 from Denizli State Hospital and Servergazi State Hospital. Demographic population data 
were obtained from the Statistical Office of Health Directorate of the Denizli and from web-based 
public services of General Directorate of Civil Registration and Nationality, 2011; Address-Based 
Population Registration System, 2011, and the Turkish Statistical Institute Website (TurkStat, 2011). 
Statistical significance was assessed using the significance test of two proportions in SPSS.  
RESULTS
The population of Denizli was 423,850 females and 429,179 males in 2000 and 
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467,719 females and 464,419 males in 2010. The national mean age of the pregnancy was 
27 years old and the crude birth rate was 18.67 from 2001-2010 in Denizli. We identified 113 
DS live births between 1994 and 2010, 55 females and 58 males. The DS live birth distribu-
tion in each year is shown in Figure 1. Before 2000, 32 DS live birth were detected during a 
6-year period, and in the 2000s, 81 DS live births were detected during a 10-year period. Data 
on maternal age could not be obtained from electronic registries of the hospitals. The DS live 
birth number increased 50% in the 2000s. A large proportion of this increase was caused by 
the extraordinarily high live birth number in 2006.
Figure 1. Down syndrome (DS) live birth distribution in years.
Overall live birth prevalence of DS was 7.06 during the 16 years. We could calculate 
only a 4-year prevalence of DS as 9.07 DS per 10,000 live birth from 1997-1999, because we 
could not obtain live birth numbers from 1994-1996. The prevalence of DS from 2000-2009 
was 9.90 DS per 10,000 live births. The prevalence during the first five years of the 2000s 
(2000-2004) was 7.59, while it was 13.40 for the second five years (2005-2009) (Table 1).
                                                                Period of years
 1996-1999 2000-2004 2005-2009 2000-2009
 32 (9.07) 33 (7.59) 49 (13.40) 82 (9.90)
Table 1. Down syndrome live birth numbers and prevalence by years.
Data are reported as number of cases with prevalence in parentheses.
In Denizli, the female age distribution is advancing to a high-risk group; in contrast, 
the fertility rate decreases with age (Tables 2 and 3).
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DISCUSSION
If we consider the national demographic structure during the last two decades, we can 
see that the population increased 30%, while the annual growth rate decreased 20% in the first 
decade and 1% in the second decade. Mean age at first marriage of women increased from 21 
to 23 years old (Marriage Statistics, 2012). First childbearing age slightly increased from 26.9 
to 27.2 years old. Total fertility rate decreased from exactly 3 to 2 children. Additionally, the 
crude birth rate decreased 16.6% in the first decade and 7.5% in the second decade (General 
Directorate of Civil Registration and Nationality Website, 2011; Turkey in Statistics 2011 
Booklet, 2011; Turkish Statistical Institute Website, 2011). Women at fertile age (15-49 years 
old) increased 22.5 and 7.7% in the first and second decades, respectively. However, there was 
a decreasing trend of 30-50% in the fertility rate (Turkish Statistical Institute Website, 2011).
According to the report of the 2003 Turkey Demographic and Health Survey, most fami-
lies agree that the ideal number of children is two, and desire to bear children is concentrated on 
the 19-29-year-old group (80%). By the age of 30-34 years, the proportion dramatically declines 
to 19%, and 83% of women at age 40-44 prefer to limit childbearing (Unalan and Yavuz, 2004).
In contrast with data from Turkey, mothers of 35 years and over have increased by 
25% in some regions of the European Union (EU) by 1999. Additionally, in Turkey there are 
no legal restrictions against abortion, in contrast to some EU countries. Although live birth 
prevalence of DS varied between these regions; total prevalence was reported as 1-3/1000 
births in the EU (Dolk et al., 2005; Weijerman et al., 2010; de Graaf et al., 2011).
Through a rough estimation based on the Turkey Disability Survey (2002, 2011), the na-
tional prevalence of DS is 8-10/100,00 live births. Gender distribution is fairly balanced in our reg-
istries (51.3% male), compared to 53.1% males among the Down’s cases of Balkan et al. (2010) and 
54.6% males by Duarte et al. (2004); however, Takeuchi et al. (2008) reported a gender ratio of 1.55.
In the United States, the fertility rate at advanced maternal ages has increased, which 
has caused an increase in the prevalence of DS at birth. It was reported that DS prevalence was 
increased from 9.0 to 11.8 per 10,000 live births in 10 USA regions during a 25-year period 
(1979-2003) (Olsen et al., 2003; Shin et al., 2009).
Year                Age group of mother     Total
 <15 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50+ UN
2001   12 1780 5528 4207 2169 877 119 14 2 20 14,728
2009     3 1017 4055 4470 2518 840 115   8 1 44 13,071
Table 2. Age group distribution of fertile women in two decades in Denizli.
a2000 census of population; bAddress-Based Population Registration System.
Year    Age groups    Total
 15-49 20-24 25-29 30-34 35-39 40-44 45-49
2000a 40,415 39,909 35,349 32,794 32,147 27,782 23,440 231,836
2010b  34,971 36,476 38,572 40,040 35,466 32,189 32,106 249,820
Table 3. Births by statistical regions of Europe and age group of mother in Denizli.
Source = General Directorate of Civil Registration and Nationality; birth statistics have been started to publish by the permanent residence 
since 2009. UN = unknown.
©FUNPEC-RP www.funpecrp.com.brGenetics and Molecular Research 11 (4): 4640-4645 (2012)
I. Acikbas et al. 4644
The live birth prevalence of DS has been increasing in Japan since 1970; the increas-
ing frequency of DS is attributed to advanced maternal age (Hoshi et al., 1999; Kajii, 2008; 
Takeuchi et al., 2008). In contrast, the live birth prevalence of DS has decreased (from 1.17 
to 0.89/1000) over the years, from 1993 to 1998 in Singapore, due to antenatal diagnosis and 
elective abortion (Lai et al., 2002).
Informational and awareness-raising activities are organized as public health policy 
in Turkey. Almost all of the pregnancies are followed up by an obstetrician and routine triple 
screening tests are performed, and in case of necessity, all the cases can easily include prenatal 
chromosomal abnormality analysis. Over 95% of births are attended by skilled health personal 
(WHO Turkey Health Profile 2011 Report, 2011). Although in some other parts of the world 
only a minority of mothers give birth in hospital, most pregnant women, with or without 
complications, give birth in hospitals in Turkey (Carothers et al., 1999). These conditions help 
most DS birth to be diagnosed. These actions taken together contribute to achieve the goal of 
a stable prevalence trend. 
European Surveillance of Congenital Anomalies (EUROCAT) has been founded with 
the goal of improving the collection of data about congenital disorders from 18 EU coun-
tries, although many countries have different registration databases that are incomplete, such 
as National Birth Defects Prevention Network - Congenital Anomaly Multistate Prevalence 
and Survival (CAMPS) Collaborative in the USA, the National Down Syndrome Cytogenetic 
Register in the UK, the National Cytogenetic Network National Neonatology Registration - 
Working Group for Prenatal Diagnostics and Therapeutics in The Netherlands, and the Hun-
garian Congenital Abnormality (Dolk et al., 2005; Métneki and Czeizel, 2005; Weijerman et 
al., 2010; de Graaf et al., 2011; EUROCAT, 2011). In Turkey, the National Health Net will be 
activated soon. This will help estimate and calculate with more precision and uninterrupted 
data, and develop more efficient health policies for both young and advanced maternal age 
groups.
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